Skip to main content
Clinical Trials/CTRI/2023/12/060768
CTRI/2023/12/060768
Recruiting
Phase 4

ow Birthweight and Preterm Infant Feeding Trial and Supportive Care Package (LIFT-UP) - LIFT-UP

Bill and Melinda Gates Foundation0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: P071- Other low birth weight newbornHealth Condition 2: P073- Preterm [premature] newborn [other]
Sponsor
Bill and Melinda Gates Foundation
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Bill and Melinda Gates Foundation

Eligibility Criteria

Inclusion Criteria

  • 1\. Very LBW ( \<1\.5 kg) or very preterm ( \<32 weeks) admitted to NICU at study facility \<24 hours after birth for in\-born infants and up to 48 hours for out\-born (timing of admission may be extended to meet sample size goals)
  • 2\. Mother and infant alive during screening
  • 3\. Mother age 18\+ years (India and Tanzania) or 16\-18 and married (Malawi only)
  • 4\. Lives within catchment areas of the facility (50km)
  • 5\. Infant receiving at least 60 mL/kg/day of human milk
  • For Qualitative Research
  • 1\. Stakeholders with some familiarity with or expertise regarding the use of probiotics for very preterm infants within the study country
  • 2\. Key stakeholder consents for him/herself

Exclusion Criteria

  • 1\. Lives outside the defined catchment area
  • 2\. Congenital abnormalities or acquired conditions that interfere with feeding or placement of NG/OG tube \[cleft lip/palate, Toxoplasmosis, other agents, rubella, cytomegalovirus, and herpes (TORCH), Trisomy 21, Congenital cardiac defect, neural tube defect, gastrointestinal (GI) tract anomalies, hydrocephalus, NEC]
  • 3\. Severe birth asphyxia
  • 4\. Critically ill (i.e. not on enteral feeds)
  • 5\. Unknown date of birth and unknown gestational age
  • For Qualitative Research

Outcomes

Primary Outcomes

Not specified

Similar Trials